RANI Insider Trading

Insider Ownership Percentage: 52.29%
Insider Buying (Last 12 Months): $1,044,151.94
Insider Selling (Last 12 Months): $853,881.28

Rani Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Rani Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Rani Therapeutics Share Price & Price History

Current Price: $5.57
Price Change: +0.30 (1.20%)
As of 02/2/2023 01:00 AM ET

This chart shows the closing price history over time for RANI up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Rani Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/28/2022South Cone Investments LimitedMajor ShareholderBuy9,157$5.58$51,096.066,697,454View SEC Filing Icon  
12/19/2022South Cone Investments LimitedMajor ShareholderBuy6,900$7.43$51,267.006,688,297View SEC Filing Icon  
12/16/2022South Cone Investments LimitedMajor ShareholderBuy6,400$7.76$49,664.006,681,397View SEC Filing Icon  
12/12/2022South Cone Investments LimitedMajor ShareholderBuy12,500$8.04$100,500.006,646,628View SEC Filing Icon  
12/9/2022South Cone Investments LimitedMajor ShareholderBuy12,345$8.01$98,883.456,634,128View SEC Filing Icon  
12/7/2022South Cone Investments LimitedMajor ShareholderBuy600$7.94$4,764.006,609,588View SEC Filing Icon  
12/5/2022South Cone Investments LimitedMajor ShareholderBuy12,195$7.97$97,194.156,596,488View SEC Filing Icon  
12/2/2022South Cone Investments LimitedMajor ShareholderBuy9,819$8.16$80,123.046,584,293View SEC Filing Icon  
11/30/2022South Cone Investments LimitedMajor ShareholderBuy8,000$7.93$63,440.006,574,272View SEC Filing Icon  
11/28/2022South Cone Investments LimitedMajor ShareholderBuy3,720$7.95$29,574.006,566,272View SEC Filing Icon  
11/25/2022South Cone Investments LimitedMajor ShareholderBuy800$7.84$6,272.006,562,552View SEC Filing Icon  
11/23/2022South Cone Investments LimitedMajor ShareholderBuy3,396$7.84$26,624.646,561,752View SEC Filing Icon  
11/21/2022South Cone Investments LimitedMajor ShareholderBuy3,200$7.87$25,184.006,545,856View SEC Filing Icon  
11/18/2022South Cone Investments LimitedMajor ShareholderBuy13,300$7.49$99,617.006,542,656View SEC Filing Icon  
11/2/2022Cortes Isidoro Alfonso QuirogaMajor ShareholderBuy25,197$6.31$158,993.075,247,786View SEC Filing Icon  
10/31/2022Cortes Isidoro Alfonso QuirogaMajor ShareholderBuy16,523$6.11$100,955.535,218,821View SEC Filing Icon  
8/17/2022Mir A ImranDirectorSell80,252$10.64$853,881.2866,445View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Rani Therapeutics (NASDAQ:RANI)

6.43% of Rani Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at RANI by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Rani Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/18/2022TPB Wealth Advisors48,129$0.46M0.2%-33.0%0.098%Search for SEC Filing on Google Icon
11/16/2022Alphabet Inc.714,471$6.85M0.3%N/A1.453%Search for SEC Filing on Google Icon
11/15/2022Jacobs Levy Equity Management Inc.18,712$0.18M0.0%N/A0.038%Search for SEC Filing on Google Icon
11/15/2022Vanguard Group Inc.650,978$6.24M0.0%+95.4%1.324%Search for SEC Filing on Google Icon
11/15/2022BlackRock Inc.202,907$1.94M0.0%-1.9%0.413%Search for SEC Filing on Google Icon
11/3/2022Motco48,129$0.46M0.0%N/A0.098%Search for SEC Filing on Google Icon
10/28/2022Lafayette Investments Inc.19,893$0.19M0.1%N/A0.040%Search for SEC Filing on Google Icon
10/17/2022Canton Hathaway LLC16,200$0.16M0.1%+88.4%0.033%Search for SEC Filing on Google Icon
10/14/2022Iowa State Bank18,862$0.18M0.1%N/A0.038%Search for SEC Filing on Google Icon
8/18/2022Goldman Sachs Group Inc.10,739$0.11M0.0%-60.0%0.022%Search for SEC Filing on Google Icon
8/15/2022Millennium Management LLC111,781$1.16M0.0%+243.7%0.227%Search for SEC Filing on Google Icon
8/8/2022Islay Capital Management LLC9,611$99K0.1%N/A0.020%Search for SEC Filing on Google Icon
8/8/2022Crossvault Capital Management LLC14,285$0.15M0.1%N/A0.029%Search for SEC Filing on Google Icon
7/29/2022Aspireon Wealth Advisors71,811$0.74M0.3%N/A0.146%Search for SEC Filing on Google Icon
7/20/2022Canton Hathaway LLC8,600$89K0.0%N/A0.017%Search for SEC Filing on Google Icon
6/15/2022Lasry Marc62,828$0.85M0.4%N/A0.128%Search for SEC Filing on Google Icon
6/7/2022Bank of America Corp DE3,155$42K0.0%-28.7%0.006%Search for SEC Filing on Google Icon
5/17/2022Lasry Marc62,828$0.85M0.4%N/A0.128%Search for SEC Filing on Google Icon
5/16/2022Goldman Sachs Group Inc.26,820$0.36M0.0%N/A0.055%Search for SEC Filing on Google Icon
5/16/2022State Street Corp26,142$0.35M0.0%+32.7%0.053%Search for SEC Filing on Google Icon
5/16/2022UBS Group AG3,570$48K0.0%-31.2%0.007%Search for SEC Filing on Google Icon
5/13/2022Vanguard Group Inc.290,107$3.92M0.0%+1.6%0.590%Search for SEC Filing on Google Icon
5/13/2022United Services Automobile Association481,300$6.50M0.1%N/A0.979%Search for SEC Filing on Google Icon
5/12/2022BlackRock Inc.157,374$2.13M0.0%+37.7%0.320%Search for SEC Filing on Google Icon
5/11/2022JPMorgan Chase & Co.2,329$31K0.0%-44.4%0.005%Search for SEC Filing on Google Icon
5/4/2022Advisor Group Holdings Inc.19,343$0.26M0.0%-8.2%0.039%Search for SEC Filing on Google Icon
2/3/2022Advisor Group Holdings Inc.21,072$0.34M0.0%N/A0.043%Search for SEC Filing on Google Icon
1/6/2022Canton Hathaway LLC5,000$82K0.0%-50.0%0.010%Search for SEC Filing on Google Icon
11/16/2021Squarepoint Ops LLC50,000$0.89M0.0%N/A0.102%Search for SEC Filing on Google Icon
11/15/2021Caas Capital Management LP75,000$1.34M0.0%N/A0.153%Search for SEC Filing on Google Icon
11/10/2021Goldman Sachs Group Inc.60,649$1.08M0.0%N/A0.124%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Rani Therapeutics logo
Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed Phase I clinical trial for the treatment of neuroendocrine tumors and acromegaly; RT-105, an anti-TNF-alpha antibody to treat psoriatic arthritis; RT-102, a parathyroid hormone that is in preclinical studies for the treatment of osteoporosis; RT-109, a human growth hormone to treat growth hormone deficiency; RT-110, a parathyroid hormone for the treatment of hypoparathyroidism; and RT-106, a basal insulin for the treatment of type 2 diabetes. The company was incorporated in 2012 and is headquartered in San Jose, California.
Read More on Rani Therapeutics

Today's Range

Now: $5.57
Low: $5.30
High: $5.81

50 Day Range

MA: $6.73
Low: $5.49
High: $8.28

52 Week Range

Now: $5.57
Low: $5.11
High: $22.46

Volume

32,514 shs

Average Volume

33,219 shs

Market Capitalization

$274.94 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.52

Who are the company insiders with the largest holdings of Rani Therapeutics?

Rani Therapeutics' top insider shareholders include:
  1. South Cone Investments Limited (Major Shareholder)
  2. Cortes Isidoro Alfonso Quiroga (Major Shareholder)
  3. Mir A Imran (Director)
Learn More about top insider investors at Rani Therapeutics.

Who are the major institutional investors of Rani Therapeutics?

Rani Therapeutics' top institutional investors include:
  1. Simplex Trading LLC — 0.00%
  2. Concourse Financial Group Securities Inc. — 0.00%
Learn More about top institutional investors of Rani Therapeutics stock.

Which major investors are buying Rani Therapeutics stock?

During the last quarter, RANI stock was bought by institutional investors including:
  1. Simplex Trading LLC
During the last year, these company insiders have bought Rani Therapeutics stock:
  1. South Cone Investments Limited (Major Shareholder)
  2. Cortes Isidoro Alfonso Quiroga (Major Shareholder)
Learn More investors buying Rani Therapeutics stock.